AstraZeneca
AZN
AZN
902 hedge funds and large institutions have $31.1B invested in AstraZeneca in 2021 Q3 according to their latest regulatory filings, with 194 funds opening new positions, 419 increasing their positions, 152 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
19% more capital invested
Capital invested by funds: $26B → $31.1B (+$5.05B)
18% more funds holding
Funds holding: 767 → 902 (+135)
0.3% more ownership
Funds ownership: 33.06% → 33.36% (+0.3%)
Holders
902
Holding in Top 10
17
Calls
$925M
Puts
$625M
Top Buyers
| 1 | +$863M | |
| 2 | +$562M | |
| 3 | +$468M | |
| 4 |
Renaissance Technologies
New York
|
+$401M |
| 5 |
Legal & General Group
London,
United Kingdom
|
+$329M |
Top Sellers
| 1 | -$679M | |
| 2 | -$227M | |
| 3 | -$187M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$111M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$65.7M |